411 related articles for article (PubMed ID: 25892506)
41. Interplay of estrogen receptors and GPR30 for the regulation of early membrane initiated transcriptional effects: A pharmacological approach.
Notas G; Kampa M; Pelekanou V; Castanas E
Steroids; 2012 Aug; 77(10):943-50. PubMed ID: 22138208
[TBL] [Abstract][Full Text] [Related]
42. Is the membrane estrogen receptor, GPER1, a promiscuous receptor that modulates nuclear estrogen receptor-mediated functions in the brain?
Vajaria R; Vasudevan N
Horm Behav; 2018 Aug; 104():165-172. PubMed ID: 29964007
[TBL] [Abstract][Full Text] [Related]
43. Progesterone inhibits estrogen-mediated neuroprotection against excitotoxicity by down-regulating estrogen receptor-β.
Aguirre C; Jayaraman A; Pike C; Baudry M
J Neurochem; 2010 Dec; 115(5):1277-87. PubMed ID: 20977477
[TBL] [Abstract][Full Text] [Related]
44. Estrogen can act via estrogen receptor alpha and beta to protect hippocampal neurons against global ischemia-induced cell death.
Miller NR; Jover T; Cohen HW; Zukin RS; Etgen AM
Endocrinology; 2005 Jul; 146(7):3070-9. PubMed ID: 15817665
[TBL] [Abstract][Full Text] [Related]
45. G-protein coupled estrogen receptor (GPER1) activation promotes synaptic insertion of AMPA receptors and induction of chemical LTP at hippocampal temporoammonic-CA1 synapses.
Clements L; Alexander A; Hamilton K; Irving A; Harvey J
Mol Brain; 2023 Jan; 16(1):16. PubMed ID: 36709268
[TBL] [Abstract][Full Text] [Related]
46. Neuroprotective effects of R,R-tetrahydrochrysene against glutamate-induced cell death through anti-excitotoxic and antioxidant actions involving estrogen receptor-dependent and -independent pathways.
Xia Y; Xing JZ; Krukoff TL
Neuroscience; 2009 Aug; 162(2):292-306. PubMed ID: 19410635
[TBL] [Abstract][Full Text] [Related]
47. Estrogen and neuroprotection: higher constitutive expression of glutaredoxin in female mice offers protection against MPTP-mediated neurodegeneration.
Kenchappa RS; Diwakar L; Annepu J; Ravindranath V
FASEB J; 2004 Jul; 18(10):1102-4. PubMed ID: 15132975
[TBL] [Abstract][Full Text] [Related]
48. Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease.
Litim N; Morissette M; Di Paolo T
Neurosci Biobehav Rev; 2016 Aug; 67():79-88. PubMed ID: 26708712
[TBL] [Abstract][Full Text] [Related]
49. G-protein coupled estrogen receptor 1 mediated estrogenic neuroprotection against spinal cord injury.
Hu R; Sun H; Zhang Q; Chen J; Wu N; Meng H; Cui G; Hu S; Li F; Lin J; Wan Q; Feng H
Crit Care Med; 2012 Dec; 40(12):3230-7. PubMed ID: 22975889
[TBL] [Abstract][Full Text] [Related]
50. Estrogen receptors and lesion-induced response of striatal dopamine receptors.
Al Sweidi S; Morissette M; Rouillard C; Di Paolo T
Neuroscience; 2013 Apr; 236():99-109. PubMed ID: 23357113
[TBL] [Abstract][Full Text] [Related]
51. Estrogen receptor subtypes mediate distinct microvascular dilation and reduction in [Ca2+]I in mesenteric microvessels of female rat.
Mazzuca MQ; Mata KM; Li W; Rangan SS; Khalil RA
J Pharmacol Exp Ther; 2015 Feb; 352(2):291-304. PubMed ID: 25472954
[TBL] [Abstract][Full Text] [Related]
52. Estrogen receptors observed at extranuclear neuronal sites and in glia in the nucleus accumbens core and shell of the female rat: Evidence for localization to catecholaminergic and GABAergic neurons.
Almey A; Milner TA; Brake WG
J Comp Neurol; 2022 Aug; 530(11):2056-2072. PubMed ID: 35397175
[TBL] [Abstract][Full Text] [Related]
53. Oxabicycloheptene Sulfonate Protects Against β-Amyloid-induced Toxicity by Activation of PI3K/Akt and ERK Signaling Pathways Via GPER1 in C6 Cells.
Deng LJ; Cheng C; Wu J; Wang CH; Zhou HB; Huang J
Neurochem Res; 2017 Aug; 42(8):2246-2256. PubMed ID: 28374135
[TBL] [Abstract][Full Text] [Related]
54. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
[TBL] [Abstract][Full Text] [Related]
55. The neuroprotective effects of novel estrogen receptor GPER1 in mouse retinal ganglion cell degeneration.
Jiang M; Ma X; Zhao Q; Li Y; Xing Y; Deng Q; Shen Y
Exp Eye Res; 2019 Dec; 189():107826. PubMed ID: 31586450
[TBL] [Abstract][Full Text] [Related]
56. Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780.
Meyer MR; Baretella O; Prossnitz ER; Barton M
Pharmacology; 2010; 86(1):58-64. PubMed ID: 20639684
[TBL] [Abstract][Full Text] [Related]
57. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
[TBL] [Abstract][Full Text] [Related]
58. Estrogen receptors and type 1 metabotropic glutamate receptors are interdependent in protecting cortical neurons against β-amyloid toxicity.
Spampinato SF; Molinaro G; Merlo S; Iacovelli L; Caraci F; Battaglia G; Nicoletti F; Bruno V; Sortino MA
Mol Pharmacol; 2012 Jan; 81(1):12-20. PubMed ID: 21984253
[TBL] [Abstract][Full Text] [Related]
59. Estrogen protects against dopamine neuron toxicity in primary mesencephalic cultures through an indirect P13K/Akt mediated astrocyte pathway.
Bains M; Roberts JL
Neurosci Lett; 2016 Jan; 610():79-85. PubMed ID: 26520464
[TBL] [Abstract][Full Text] [Related]
60. The effects of estrogen receptors α- and β-specific agonists and antagonists on cell proliferation and energy metabolism in human bone cell line.
Somjen D; Katzburg S; Sharon O; Grafi-Cohen M; Knoll E; Stern N
J Cell Biochem; 2011 Feb; 112(2):625-32. PubMed ID: 21268084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
